111-57-9
中文名稱(chēng)
硬脂酰胺 MEA
英文名稱(chēng)
STEAROYL ETHANOLAMIDE
CAS
111-57-9
分子式
C20H41NO2
分子量
327.55
MOL 文件
111-57-9.mol
更新日期
2026/07/14 13:33:56
111-57-9 結(jié)構(gòu)式
基本信息
中文別名
十八酰胺乙醇硬脂酰胺 MEA
硬脂酸單乙醇酰胺
N-(2-羥基乙基)硬脂酰胺
N-(2-羥基乙基)十八烷酰胺
英文別名
SEAAM-1105
CERAMID
STEARAMIDE MEA
STEAROYL ETHANOLAMIDE
N-Stearoylethanolamide
stearic monoethanolamide
Stearyl monoethanolamide
STEARIC ACID ETHANOLAMIDE
Stearoylethanolamide(SEA)
所屬類(lèi)別
化學(xué)試劑：酰胺物理化學(xué)性質(zhì)
熔點(diǎn)103-104 °C(Solv: ethanol (64-17-5))
沸點(diǎn)486.0±28.0 °C(Predicted)
密度0.904±0.06 g/cm3(Predicted)
蒸氣壓0Pa at 20℃
儲(chǔ)存條件−20°C
溶解度DMF: >2 mg/ml; DMSO: >100 μg/ml; Ethanol: >2 mg/ml; PBS pH 7.2: >100 μg/ml
酸度系數(shù)(pKa)14.49±0.10(Predicted)
形態(tài)crystalline
顏色White to light yellow
水溶解性1mg/L at 20℃
化妝品成分功效VISCOSITY CONTROLLING
SURFACTANT - FOAM BOOSTING
ANTISTATIC
SURFACTANT - FOAM BOOSTING
ANTISTATIC
InChIInChI=1S/C20H41NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-20(23)21-18-19-22/h22H,2-19H2,1H3,(H,21,23)
InChIKeyOTGQIQQTPXJQRG-UHFFFAOYSA-N
SMILESC(NCCO)(=O)CCCCCCCCCCCCCCCCC
LogP4.46 at 20℃
EPA化學(xué)物質(zhì)信息N-(2-Hydroxyethyl)octadecanamide (111-57-9)
安全數(shù)據(jù)
警示詞危險(xiǎn)
危險(xiǎn)性描述H315-H318-H402-H412
安全說(shuō)明22-24/25
WGK Germany2
TSCATSCA listed
REACH 注冊(cè)登記Active
存儲(chǔ)類(lèi)別11 - Combustible Solids
N-(2-羥基乙基)硬脂酰胺價(jià)格(試劑級(jí))
| 報(bào)價(jià)日期 | 產(chǎn)品編號(hào) | 產(chǎn)品名稱(chēng) | CAS號(hào) | 包裝 | 價(jià)格 |
| 2026/06/05 | HY-113015R | N-(2-羥基乙基)硬脂酰胺 Stearoylethanolamide (Standard) | 111-57-9 | 5 mg | 1250元 |
| 2026/06/05 | HY-113015R | N-(2-羥基乙基)硬脂酰胺 Stearoylethanolamide (Standard) | 111-57-9 | 10 mg | 1880元 |
| 2026/06/05 | HY-113015R | N-(2-羥基乙基)硬脂酰胺 Stearoylethanolamide (Standard) | 111-57-9 | 25 mg | 3380元 |
常見(jiàn)問(wèn)題列表
生物活性
Stearoylethanolamide 是一種具有促細(xì)胞凋亡活性的內(nèi)源性大麻素類(lèi)化合物。靶點(diǎn)
|
Human Endogenous Metabolite
|
體外研究
Stearoylethanolamide (SEA) is present in human, rat and mouse brain in amounts comparable with those of the endocannabinoid anandamide (arachidonoylethanolamide; AEA). Stearoylethanolamide is an endocannabinoid-like compound with pro-apoptotic activity, which is regulated by NO in a way opposite to that reported for AEA.